4//SEC Filing
Schorno Dean L 4
Accession 0000905148-25-000413
CIK 0001034842other
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 8:27 PM ET
Size
6.0 KB
Accession
0000905148-25-000413
Insider Transaction Report
Form 4
Schorno Dean L
EVP & Chief Financial Officer
Transactions
- Sale
Common Stock
2025-02-04$20.92/sh−2,036$42,595→ 58,969 total - Sale
Common Stock
2025-02-05$21.93/sh−1,734$38,020→ 57,235 total
Footnotes (1)
- [F1]These shares were sold to cover tax withholding due upon vesting of Restricted Stock Units. Such "sales to cover" were automatically effected to satisfy tax withholding obligations and do not represent a discretionary trade by the Reporting Person.
Documents
Issuer
RIGEL PHARMACEUTICALS INC
CIK 0001034842
Entity typeother
Related Parties
1- filerCIK 0001509688
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 8:27 PM ET
- Size
- 6.0 KB